A new drug compound could combat tough-to-treat melanoma
Melanoma is commonly caused by the damaging effects of ultraviolet light—from sources like sunlight and tanning beds—on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells to further mutate into full-blown skin cancer. At the same time, UV damage can turn off other genes that would normally prevent tumor growth. With enough wrongly flipped switches, cancer can flourish. And melanoma is certainly flourishing. This year alone, 96,480 new instances of melanoma will be diagnosed in the United States and 7,230 Americans will die from the disease.
With so many people affected by melanoma, scientists are on the hunt for better ways to screen for melanoma risk and treat the most lethal types of skin cancer. One particularly voracious type of melanoma, caused by mutation of a gene called NRAS (which instructs cells to produce a protein of the same name, NRAS), drives 25 percent of skin cancers.
“There are immunotherapies and targeted therapies that have shown huge improvements for patients with melanoma,” said Rutao Cui, a Boston University School of Medicine professor of pharmacology and dermatology. “However, for patients with NRAS mutations, they don’t have very useful or very effective treatment strategies.”
Now, an international research team led by Cui has discovered a new way to stop the progression of melanoma by NRAS mutations with the flip of a genetic switch. Their findings were published January 31, 2019, in Cell.
Inside our bodies, proteins like NRAS play the role of dominoes, interacting with one another to switch other important gene activities on or off. The researchers set out in search of a way to interrupt the process in which mutated NRAS can instigate the growth of skin cancer. Since targeting the NRAS gene—just one of several dominoes in this type of skin cancer pathway—has proven to be so difficult, the researchers were determined to find another approach.
For NRAS to trigger cancer development, it first needs to be activated by another protein in the body. Until now, it’s been unknown exactly which protein is responsible for activating NRAS. But after testing the effect of several different proteins on the activity of NRAS, the team zeroed in on a likely culprit, a protein by the name of STK19.
STK19 is not a newly discovered protein in its own right, but its purpose has not been known until now. Cui’s team found that STK19 appears to work as an “on” switch for NRAS—activating production of NRAS proteins which, in turn, trigger the toppling of several other genetic dominoes downstream.
The researchers also found that, unlike NRAS, they could disable the STK19 gene and greatly diminish its ability to set the skin cancer sequence in motion.
Together, the team designed a new drug compound to shut down the effect of STK19 on NRAS. Then, testing its effect on skin cells cultured in petri dishes and in animal models, they proved that their compound can block NRAS activation and prevent melanoma from developing.
Cui says that this result is exciting not just for melanoma, but for other cancers as well. While the relationship between STK19 and NRAS may be particular to skin cancer, the approaches the team used to identify and block key activating proteins can be applied to find new treatments for similarly difficult-to-cure cancers.
Now the research team is looking to take their research to clinical trials to test out the STK19 inhibitor in humans, and hopefully, someday make it available as a targeted therapy to combat NRAS-driven melanomas.
In the meantime, Cui says that much work still needs to be done to not only create better and more precise treatments for patients suffering with melanoma, but also to alert vulnerable populations about the risk factors associated with the cancer.
“We need more monitoring for early diagnosis and full-body examinations for problematic spots,” says Cui, “and more proactive strategies for patients [at the highest risk of developing melanoma] to prevent cancer progression and metastasis.”
Learn more: Shutting Down Skin Cancer
The Latest on: Skin cancer
via Google News
The Latest on: Skin cancer
- Gov. Hogan Tweets After Having Skin Cancer Removedon January 18, 2021 at 9:33 pm
Gov. Larry Hogan tweeted a photo Saturday ahead of the Ravens game. Bills Fans Donate To Lamar Jackson's Favorite Charity After Ravens QB's ConcussionThe Baltimore Ravens lost to the Buffalo Bills on ...
- Maryland Gov. Larry Hogan tweets photo after skin cancer removal: 'No pain, no gain'on January 16, 2021 at 11:46 pm
Maryland Gov. Larry Hogan Saturday tweeted a photo of himself following a procedure to remove cancerous cells from his face.
- Miiskin Fights Cancer by Helping You Monitor Skin Changeson January 15, 2021 at 9:54 am
Miiskin makes it simple to monitor your skin for moles and other skin changes that could be signs of cancer, even on hard-to-examine areas like your back.
- Global Non-Melanoma Skin Cancer Market Size 2021, Share, Growth, Industry Analysis and Future Demand, Top Key Players and Forecast 2026on January 14, 2021 at 4:45 pm
Melanoma Skin Cancer Market provides detailed analysis of Market Overview, Drivers, Prospects, Potential Application. Also Non-Melanoma Skin Cancer Industry research report includes the future impact ...
- Does Screening for Skin Cancer Result in Melanoma Overdiagnosis?on January 14, 2021 at 8:11 am
Screening for skin cancer should stop, as it is contributing to an overdiagnosis of melanoma, say NEJM authors, but the issue is nuanced, retort melanoma experts.
- Skin Cancer Market Growth Insights, Regional Outlook, Share Estimation, Size Value, Key Profile and COVID-19 Impact Analysis By 2023on January 14, 2021 at 2:37 am
Skin Cancer Market Analysis The skin cancer market is projected to grow at an 8.8% CAGR between 2017-2023, states the ...
- Gov. Larry Hogan To Get Surgery For Skin Canceron January 13, 2021 at 12:18 pm
Gov. Larry Hogan will undergo outpatient surgery this week for skin cancer, according to his spokesman. "On Friday, Governor Hogan will have minor outpatient surgery," Mike Ricci, communications ...
- Maryland Governor to Have Surgery to Remove Skin Canceron January 13, 2021 at 10:39 am
Maryland Gov. Larry Hogan said Wednesday he will have minor surgery this week to remove early-stage skin cancer. Hogan made the announcement at the end of an interview about the state’s legislative ...
- Maryland governor to have surgery to remove early-stage skin canceron January 13, 2021 at 10:25 am
Maryland Gov. Larry Hogan announced on Wednesday that he will be having surgery on Friday to remove early-stage skin cancer.The Republican governor announced that he had early-stage basal and squamous ...
- Hogan to undergo surgery to remove cancer cells from skinon January 13, 2021 at 10:22 am
Gov. Larry Hogan is undergoing surgery Friday to remove cancer cells from his face and shoulder, his communications director Mike Ricci announced in a tweet Wednesday.
via Bing News